Member access

4-Traders Homepage  >  Shares  >  Nyse  >  MEDNAX Inc    MD   US58502B1061

MEDNAX INC (MD)

5
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales1 5881 8172 1542 4142 6532 898
Operating income (EBITDA)381420492556604657
Operating profit (EBIT)355390452511556612
Pre-Tax Profit (EBT)-388448---
Net income218241281316343372
EPS ( $)2,242,432,783,143,413,72
Dividend per Share ( $)------
Yield------
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt6,74116----
Finance--10,444,1241470
Operating income (EBITDA)381420492556604657
Leverage
(Debt/EBITDA)
0,02x0,28x----
Capital Expenditure31,314,515,619,122,025,8
Book Value Per Share (BVPS)17,7 $20,3 $23,2 $25,3 $28,4 $32,6 $
Cash Flow per Share2,78 $3,28 $4,02 $3,88 $4,26 $4,80 $
Announcement Date02/02/2012
11:00am
01/31/2013
11:00am
01/30/2014
11:00am
---
Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 5 560 M$ -
Entreprise Value (EV) 5 516 M$ 5 319 M$
Valuation 2014e 2015e
PER (Price / EPS) 17,6x 16,3x
Capitalization / Revenue 2,30x 2,10x
EV / Revenue 2,28x 2,00x
EV / EBITDA 9,92x 8,81x
Yield (DPS / Price) - -
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 21,2% 21,0%
operating Leverage (Delta EBIT / Delta Sales) 1,08x 0,89x
Net Margin (Net Profit / Revenue) 13,1% 12,9%
ROA (Net Profit / Asset) 9,60% 9,53%
ROE (Net Profit / Equities) 12,5% 3,92%
Rate of Dividend - -
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   0,79% 0,83%
Cash Flow / Sales (Taux d'autofinancement) 16,1% 16,1%
Capital Intensity (Assets / Sales) 1,36x 1,36x
Financial Leverage (Net Debt / EBITDA) -0,08x -0,40x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF